S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
"Prepare for Five Years of Famine" (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Modern Day Options Trading For Beginners! (Ad)pixel
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
"Prepare for Five Years of Famine" (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Modern Day Options Trading For Beginners! (Ad)pixel
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
"Prepare for Five Years of Famine" (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Modern Day Options Trading For Beginners! (Ad)pixel
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
My No. 1 dividend stock for a LIFETIME of income. (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
"Prepare for Five Years of Famine" (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Modern Day Options Trading For Beginners! (Ad)pixel
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment

Bunge - BG Price Target & Analyst Ratings

$95.83
+1.90 (+2.02%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$94.40
$96.62
50-Day Range
$91.39
$104.62
52-Week Range
$80.41
$128.40
Volume
1.26 million shs
Average Volume
1.94 million shs
Market Capitalization
$14.37 billion
P/E Ratio
9.11
Dividend Yield
2.61%
Price Target
$125.13

Bunge Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 8 Analyst Ratings

Consensus Analyst Price Target

$125.13
30.57% Upside
High Prediction$135.00
Average Prediction$125.13
Low Prediction$106.00
TypeCurrent
3/28/22 to 3/28/23
1 Month Ago
2/26/22 to 2/26/23
3 Months Ago
12/28/21 to 12/28/22
1 Year Ago
3/28/21 to 3/28/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
7 Buy rating(s)
7 Buy rating(s)
6 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$125.13$125.13$122.25$106.00
Predicted Upside30.57% Upside32.48% Upside29.17% Upside11.90% Upside
Get Bunge Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for BG and its competitors with MarketBeat's FREE daily newsletter.

BG Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Bunge Stock vs. The Competition

TypeBungeBasic Materials CompaniesS&P 500
Consensus Rating Score
2.88
2.59
2.47
Consensus RatingModerate BuyBuyHold
Predicted Upside30.57% Upside212.38% Upside22.48% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/9/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Neutral$127.00 ➝ $115.00+17.12%
12/13/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$133.00+40.79%
10/24/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$138.00 ➝ $130.00+43.98%
8/12/2022Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$127.00+28.82%
7/7/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Thomas Palmer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Overweight$130.00 ➝ $106.00+23.47%
7/6/2022Monness Crespi & Hardt
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$130.00+51.62%
6/24/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$140.00 ➝ $125.00+43.04%
4/25/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Benjamin Theuer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight$120.00 ➝ $135.00+17.32%
1/13/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$98.00 ➝ $92.00-7.76%
10/28/2021BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$98.00 ➝ $108.00+19.18%
10/28/2021Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$100.00 ➝ $110.00+21.39%
(Data available from 3/28/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












BG Price Target - Frequently Asked Questions

What is Bunge's consensus rating and price target?

According to the issued ratings of 8 analysts in the last year, the consensus rating for Bunge stock is Moderate Buy based on the current 1 hold rating and 7 buy ratings for BG. The average twelve-month price prediction for Bunge is $125.13 with a high price target of $135.00 and a low price target of $106.00. Learn more on BG's analyst rating history.

Do Wall Street analysts like Bunge more than its competitors?

Analysts like Bunge more than other Basic Materials companies. The consensus rating for Bunge is Moderate Buy while the average consensus rating for basic materials companies is Buy. Learn more on how BG compares to other companies.

Is Bunge being downgraded by Wall Street analysts?

Over the previous 90 days, Bunge's stock had 1 downgrade by analysts.

Does Bunge's stock price have much upside?

According to analysts, Bunge's stock has a predicted upside of 32.48% based on their 12-month price targets.

What analysts cover Bunge?

Bunge has been rated by Robert W. Baird in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:BG) was last updated on 3/28/2023 by MarketBeat.com Staff